Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
COVID Symptoms |
Schedule a COVID vaccine or booster appointment:
Log in to myPennMedicine or call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Sees patients age 18 and up
Sees patients age 18 and up
In addition to Penn Medicine hospital privileges, I also have privileges at Cape Regional Medical Center, an affiliate of Penn Cardiology.
Penn Presbyterian Medical Center
Heart and Vascular Pavilion, 3rd Floor
51 N. 39th Street
Philadelphia, PA 19104
Penn Medicine Cherry Hill
1865 Route 70 East
Cherry Hill, NJ 08003
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown above from our internal platform, PMX Feedback. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Saybolt MD, Lilly SM, Patel D, Hamamdzic D, Llano R, Fenning RS, Madden S, Wilensky RL: The vulnerable artery: early and rapid deposition of lipid in coronary arteries is associated with subsequent development of thin-cap fibroatheromas EuroIntervention 11 (14): e1612-8,2016.
Fenning RS, Burgert ME, Hamamdzic D, Peyster EG, Mohler ER 3rd, Kangovi S, Jucker BM, Lenhard S, Li J, Hoffman BE, Macphee CH, Wilensky RL: Atherosclerosis differs between vascular sites by plaque severity, gene expression, and the role of lipoprotein-associated phospholipase A2 J Am Heart Assoc 4 (2): 2015.
Fenning RS and Wilensky RL: New insights into the vulnerable plaque from imaging studies. Curr Atheroscler Rep. 16 (3): 397-397,2014.
Merschen RJ, Fenning RS, Wascho R, and Goldberg SM: Saphenous vein graft to left circumflex stenting with significant distal and proximal disease: a complex case utilizing a covered stent. Cath Lab Digest 1 (22): 1-3,2014.
Patel D, Hamamdzic D, Llano R, Patel D, Cheng L, Fenning RS, Bannan K, Wilensky RL: Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy. Thromb Vasc Biol 33 (2): 347-353,2013.
Patel D, Hamamdzic D, Llano R, Patel D, Cheng L, Fenning RS, Bannan K, and Wilensky RL: Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy. Arterioscler Thromb Vasc Biol 33 (2): 347-53,2013.
Qamar A, Fenning RS, Qasim AN, Mehta NN, Reilly MP, Rader DJ.: Plasma Fibroblast growth factor-21 levels are positively associated with metabolic syndrome, insulin resistance and systemic inflammation. American Heart Association Meeting, Los Angeles CA : 2012.
Fenning RS, Peyster EG, Kangovi S, Hamamdzic D, Burgert ME, Macphee CH, and Wilensky RL: Atherosclerotic plaque development differs between vascular sites with unique phenotypic and gene expression profiles. Mid-Atlantic Annual Capital Cardiology Symposium, Washington DC : 2012.
Heuer GG, Fenning RS, Brown M, Kilbaugh T, Guzman MA, Judkins AR, Rorke-Adams L, Sutton LN, Storm PB: Pulmonary edema and cardiac dysfunction after resection of a fourth ventricle tumor in a toddler: case report. Childs Nerv Syst. 27 (11): 2005-9,2011.
Fenning RS, Qamar A, Millar J, DerOhannessian S, Wolfe M, Rader DJ: PPAR-alpha and PPAR-gamma agonists modulate Fibroblast Growth Factor-21 levels in patients with the metabolic syndrome and dyslipidemia. Arteriosclerosis, Thrombosis, and Vascular Biology Meeting, Chicago, IL : 2011.
Penn Presbyterian Medical Center51 N. 39th StreetHeart and Vascular Pavilion4th Floor
Patient appointments: 800-789-7366